Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study Of The Immunogenicity Of The Yellow Fever Vaccine 17D (YFVax®) In Adults With Prior 17D Vaccination

NCT05859490 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05859490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05859490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study Of The Immunogenicity Of The Yellow Fever Vaccine 17D (YFVax®) In Adults With Prior 17D Vaccination
Lead sponsor
Oregon Health and Science University
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 1, 2023
Completion date
December 31, 2025
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunization; infection, yellow fever